Companies: 10,795·Total market cap: $144.5T
Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCLFOTCHealthcare
$6.25
+$0.66(+11.81%)
Market Cap$96618306
P/E Ratio
52W High$12.5
52W Low$0.88

Satellos Bioscience Inc. (MSCLF) Revenue

Annual & quarterly revenue history · segment & region breakdown

MSCLF · revenue · updated Jun 9, 2026

Core revenue metrics

Satellos Bioscience Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
14 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Satellos Bioscience Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
MSCLF revenue by year · MSCLF revenue history · MSCLF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Satellos Bioscience Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Satellos Bioscience Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Satellos Bioscience Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

MSCLF revenue · 4 questions

MSCLF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

MSCLF revenueMSCLF annual revenuewhat is MSCLF revenueMSCLF TTM revenue

Source: FMP · Satellos Bioscience Inc. SEC filings · GAAP · Satellos Bioscience Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026